NCT06179160 2026-03-16
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
Incyte Corporation
Phase 1 Recruiting
Incyte Corporation
Janssen Research & Development, LLC
University of California, Irvine
Hoffmann-La Roche
Tizona Therapeutics, Inc
Incyte Corporation
University of Alabama at Birmingham
Sapience Therapeutics